Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurora SpineASAPF -3.78%38 3-Year Book Growth Rate is -8.30% as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 38/100 and a GF Value™ of $0.24 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 763 Medical Devices & Instruments companies, Aurora Spine ranks worse than 71.56% on this metric.
During the past 12 months, Aurora Spine's average Book Value per Share Growth Rate was -15.80% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -8.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -4.00% per year.
During the past 10 years, the average Book Value per Share Growth Rate was -5.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Aurora Spine was 149.00% per year. The lowest was -32.10% per year. And the median was -0.85% per year.
Aurora Spine (OTCPK:ASAPF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Aurora Spine 3-Year Book Growth Rate Related Terms
ASAPF vs ABT, SYK, MDT: 3-Year Book Growth Rate Comparison
For the Medical Devices subindustry, Aurora Spine's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Aurora Spine's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of -8.30% mean?
Aurora Spine (ASAPF) has a 3-Year Book Growth Rate of -8.30% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Aurora Spine and its competitors. According to the industry distribution chart, Aurora Spine ranks #546 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 71.6%.
Is Aurora Spine's 3-Year Book Growth Rate too high?
Aurora Spine's current 3-Year Book Growth Rate is -8.30%. Based on the distribution chart, Aurora Spine ranks #546 out of 763 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aurora Spine has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's 3-Year Book Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #546 out of 763 companies for 3-Year Book Growth Rate. This places Aurora Spine in the lower half of its industry. The industry median 3-Year Book Growth Rate is 2.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 763 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current 3-Year Book Growth Rate is -8.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.24, compared to a current price of $0.14 — trading 40.1% below its estimated fair value. The current 3-Year Book Growth Rate is -8.30%. Aurora Spine's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current 3-Year Book Growth Rate is -8.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.14 is trading 40.1% below its estimated GF Value™ of $0.24.
GuruFocus considers Aurora Spine to be Possible Value Trap.
Key valuation signals for ASAPF:
3-Year Book Growth Rate: -8.30%
GF Value™: $0.24 vs. price of $0.14 (40.1% below fair value)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
38GF Score
Get the complete analysis for ASAPF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
